Skip to main content
Erschienen in: Annals of Surgical Oncology 10/2016

15.06.2016 | Breast Oncology

What Do Patients Prefer? Understanding Patient Perspectives on Receiving a New Breast Cancer Diagnosis

verfasst von: Deanna J. Attai, MD FACS, Regina Hampton, MD FACS, Alicia C. Staley, BS, MBA, MS, Andrew Borgert, PhD, Jeffrey Landercasper, MD FACS

Erschienen in: Annals of Surgical Oncology | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Background and Objective

There is variability in physician practice regarding delivery method and timeliness of test results to cancer patients. Our aim was to survey patients to determine if there was a difference between actual and preferred care for disclosure of test results.

Methods

A de-identified survey was distributed to online cancer support groups to query patients about their experience regarding communication of cancer testing and timeliness. Analyses of the differences between actual and preferred communication and wait times were performed.

Results

Overall, 1000 patients completed the survey. The analysis herein was restricted to 784 breast cancer survivors. Survey responders were predominately White (non-Hispanic; 89 %), college educated (78 %), and media ‘savvy’ (online medical media usage; 97 %). Differences between actual and preferred care were identified for the domains of mode of communication and wait times for initial breast cancer diagnostic biopsies and other tests. A total of 309 (39 %) of 784 patients received face-to-face communication for a new cancer diagnosis, with 394 (50 %) patients preferring this option (p < 0.0001). In addition, 315 (40 %) of 784 patients received their cancer biopsy result within 2 days, with 646 (82 %) patients preferring this option (p < 0.0001). Differences were also identified between actual and preferred care for multiple other test types.

Conclusions

Actual care for timeliness and modes of communication did not reflect patient-desired care. National and local initiatives to improve performance are needed. As a first step, we recommend that each patient be queried about their preference for mode of communication and timeliness, and efforts made to comply.
Literatur
1.
Zurück zum Zitat Baile WF, Buckman R, Lenzi R, Glober G, Beale EA, Kudelka AP. SPIKES—a six-step protocol for delivering bad news: application to the patient with cancer. Oncologist. 2000;5(4):302–11.CrossRefPubMed Baile WF, Buckman R, Lenzi R, Glober G, Beale EA, Kudelka AP. SPIKES—a six-step protocol for delivering bad news: application to the patient with cancer. Oncologist. 2000;5(4):302–11.CrossRefPubMed
2.
Zurück zum Zitat Rose C, Stovall E, Ganz PA, Desch C, Hewitt M. Cancer Quality Alliance: blueprint for a better cancer care system. CA Cancer J Clin. 2008;58(5):266–92.CrossRefPubMed Rose C, Stovall E, Ganz PA, Desch C, Hewitt M. Cancer Quality Alliance: blueprint for a better cancer care system. CA Cancer J Clin. 2008;58(5):266–92.CrossRefPubMed
3.
Zurück zum Zitat Purnell CA, Arnold RM. Retrospective analysis of communication with patients undergoing radiological breast biopsy. J Support Oncol. 2010;8(6):259–63.CrossRefPubMed Purnell CA, Arnold RM. Retrospective analysis of communication with patients undergoing radiological breast biopsy. J Support Oncol. 2010;8(6):259–63.CrossRefPubMed
4.
Zurück zum Zitat Butow PN, Kazemi JN, Beeney LJ, Griffin A, Dunn SM, Tattersall MHN. When the diagnosis is cancer: patient communication experiences and preferences. Cancer. 1996;77(12):2630–7.CrossRefPubMed Butow PN, Kazemi JN, Beeney LJ, Griffin A, Dunn SM, Tattersall MHN. When the diagnosis is cancer: patient communication experiences and preferences. Cancer. 1996;77(12):2630–7.CrossRefPubMed
5.
Zurück zum Zitat Choudhry A, Hong J, Chong K, et al. Patients’ preferences for biopsy result notification in an era of electronic messaging methods. JAMA Dermatol. 2015;151(5):513–20.CrossRefPubMed Choudhry A, Hong J, Chong K, et al. Patients’ preferences for biopsy result notification in an era of electronic messaging methods. JAMA Dermatol. 2015;151(5):513–20.CrossRefPubMed
6.
Zurück zum Zitat Figg WD, Smith EK, Price DK, English BC, Thurman PW, Steinberg SM, et al. Disclosing a diagnosis of cancer: where and how does it occur? J Clin Oncol. 2010;28(22):3630–5.CrossRefPubMedPubMedCentral Figg WD, Smith EK, Price DK, English BC, Thurman PW, Steinberg SM, et al. Disclosing a diagnosis of cancer: where and how does it occur? J Clin Oncol. 2010;28(22):3630–5.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Landercasper J, Linebarger JH, Ellis RL, et al. A quality review of the timeliness of breast cancer diagnosis and treatment in an integrated breast center. J Am Coll Surg. 2010;210(4):449–55.CrossRefPubMed Landercasper J, Linebarger JH, Ellis RL, et al. A quality review of the timeliness of breast cancer diagnosis and treatment in an integrated breast center. J Am Coll Surg. 2010;210(4):449–55.CrossRefPubMed
15.
Zurück zum Zitat Berman A, Teig B, Duracinsky M, et al. One day diagnosis for breast lesions: medical and psychological assessment—EVADIASEIN study [in French]. J Gynecol Obstet Biol Reprod (Paris). 2016;45(1):21–8.CrossRefPubMed Berman A, Teig B, Duracinsky M, et al. One day diagnosis for breast lesions: medical and psychological assessment—EVADIASEIN study [in French]. J Gynecol Obstet Biol Reprod (Paris). 2016;45(1):21–8.CrossRefPubMed
16.
Zurück zum Zitat Barentsz MW, Wessels H, van Diest PJ, et al. Same-day diagnosis based on histology for women suspected of breast cancer: high diagnostic accuracy and favorable impact on the patient. PLoS One. 2014;9(7):e103–5.CrossRef Barentsz MW, Wessels H, van Diest PJ, et al. Same-day diagnosis based on histology for women suspected of breast cancer: high diagnostic accuracy and favorable impact on the patient. PLoS One. 2014;9(7):e103–5.CrossRef
17.
Zurück zum Zitat Krishnan N, Fagerlin A, Skolarus TA. Rethinking patient-physician communication of biopsy results: the waiting game. JAMA Oncol. 2015;1(8):1025–6.CrossRefPubMed Krishnan N, Fagerlin A, Skolarus TA. Rethinking patient-physician communication of biopsy results: the waiting game. JAMA Oncol. 2015;1(8):1025–6.CrossRefPubMed
18.
Zurück zum Zitat Fayanju OM, Mayo TL, Spinks TE, et al. Value-based breast cancer care: a multidisciplinary approach for defining patient-centered outcomes. Ann Surg Oncol. 2016;94(4):719–28. Fayanju OM, Mayo TL, Spinks TE, et al. Value-based breast cancer care: a multidisciplinary approach for defining patient-centered outcomes. Ann Surg Oncol. 2016;94(4):719–28.
19.
Zurück zum Zitat Bleicher RJ, Ruth K, Sigurdson ER, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2(3):330–9.CrossRefPubMed Bleicher RJ, Ruth K, Sigurdson ER, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2(3):330–9.CrossRefPubMed
20.
Zurück zum Zitat Atisha DM, Rushing CN, Samsa GP, et al. A national snapshot of satisfaction with breast cancer procedures. Ann Surg Oncol. 2015;22:361–9.CrossRefPubMed Atisha DM, Rushing CN, Samsa GP, et al. A national snapshot of satisfaction with breast cancer procedures. Ann Surg Oncol. 2015;22:361–9.CrossRefPubMed
Metadaten
Titel
What Do Patients Prefer? Understanding Patient Perspectives on Receiving a New Breast Cancer Diagnosis
verfasst von
Deanna J. Attai, MD FACS
Regina Hampton, MD FACS
Alicia C. Staley, BS, MBA, MS
Andrew Borgert, PhD
Jeffrey Landercasper, MD FACS
Publikationsdatum
15.06.2016
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 10/2016
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5312-2

Weitere Artikel der Ausgabe 10/2016

Annals of Surgical Oncology 10/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.